Nov 26, 2024
Researchers uncover potential new biomarker for psychosis diagnosis
Posted by Saúl Morales Rodriguéz in categories: biotech/medical, neuroscience
The current standard of care for psychosis is a diagnostic interview, but what if it could be diagnosed before the first symptom emerged? Researchers at the Del Monte Institute for Neuroscience at the University of Rochester are pointing toward a potential biomarker in the brain that could lead to more timely interventions and personalized care.
“Establishing such biomarkers could provide a key step in changing how we care for, treat, and offer interventions to people with psychosis,” said Brian Keane, Ph.D., assistant professor of Psychiatry, Center for Visual Science, and Neuroscience at the University of Rochester Medical Center.
Keane recently co-authored an article in Molecular Psychiatry that identifies how MRI scans could reveal brain differences in people with psychosis.